Neoadjuvant TCbHP (trastuzumab biosimilar Zercepac®) in a young HER2-positive breast cancer woman with a large mass: a case report
Minerva Med
.
2022 Jul 29.
doi: 10.23736/S0026-4806.22.08296-9.
Online ahead of print.
Authors
Meifang Pan
1
,
Yang Li
1
,
Jincai Zhong
2
Affiliations
1
Department of Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
2
Department of Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China - 1093301007@qq.com.
PMID:
35904375
DOI:
10.23736/S0026-4806.22.08296-9
No abstract available